Jazz Inks Insurer Class Deal As Xyrem Antitrust Trial Nears
By Bonnie Eslinger · March 17, 2025, 8:48 PM EDT
Jazz Pharmaceuticals and a certified insurer class told a California federal judge Monday that they have reached a settlement-in-principle in antitrust litigation accusing Jazz of working with pharma rival Hikma to...
To view the full article, register now.